IDSA's Secrets:

Bioweapon Attributes Dickson FDA Yale USDOJ RICO

PubMed: TLR2

"New World Disorder"
IDSA's Persistence "Cryme Disease" book Klempner's Fraud RICO Patents Osp-A/Viral Synergy Grants Search "TLR2" Kissinger NWO Beast
Relapsing Fever Dearborn Quotes Plum Island Corixa RICO "LYMErix ▲ Disease" Myco & Erythrocytes Rx Brain Damage
Steere Falsifies Test Dearborn Booklet Russians & NYMC CDCs Patents w/SKB GarthNicolson-GWI Rockefeller/Psychiatry
IDSA's Imitators Schoen-LYMErix IDSA: "Cyst Viable" DARPA Boots CDC Confronting Crooked NIH CT Med Board Hell/NDEs
IDSA's ShellGame Weinstein's Frauds LYMErix ►Imitators Auwaerter Epstein-Barr NIH Disinfo Foreign CPS' Sexual Assaults
IDSA's Biomarkers Yale's Valid Test UConn's KidTuskegee Plum Stupid Vaccines' Brain Damage Fraud With Intent   CPS' Entrapment
IDSA's Stupid Rx
 
Not used ▲to assess LYMErix? Yale's Congen Lyme
 
IDSA ▲ self-indicts
 

 
Update on Sex Abuse
 


24 May 2012 

HOME


Natural Remedies
 

CDC writes a "bogus article" on Mycoplasma in the blood and Chronic Fatigue.
 

Lyme/LYMErix Cryme Reveals  New Paradigm in Health/Disease:
"Bacterial/Viral Coinfections";

TLR2 (fungi)Signaling Depletes IRAK1 and Inhibits Induction of Type 1 by TLR7/9  (viruses)-- 
-CV Harding, 2012  (More in the chart at the bottom of this homepage)

CFIDS = Seronegative Chronic Active EBV

"Multiple Mechanisms of Immune Suppression by B Lymphocytes" (New and Trashes Yale and IDSA)

NIH's Treatment Recommendations for Chronic Active Epstein-Borreliosis, the chronic illness also induced by OspA vaccination or exposure to molds.

The Antics of the Crazy Stalker Durland Fish and the New Genre in "Education."
 


CDC Greed (won't answer the FOIA)

ELISA = arbitrary cutoff.

Disclaimer

Overview


TUSKEGEE - By Jerry Leonard


1998, CIA Oilmen & Israelis plan to overthrow Saddam for the oil.

Bush/Gore  Oil/War-(Oct,2000)  

Bush's own explainer (Oct 2000) re: Iraq Oil




 

 

 

 PSYCHIATRIC MISDIAGNOSES:  No one who has Lyme can be diagnosed as "Bipolar."  The same is true for Multiple Sclerosis.  MS is a rule-out for Bipolar according to the DSM-IV.

Lyme is a brain disease, so no one with Lyme can be diagnosed with anything "psychiatric" and all Lyme victims should stay away from psychiatrists.

From the text of the NIH Clinical Trial below:

"4. Needlestick to collect 3 tablespoons of blood to measure blood count and thyroid levels, liver and kidney function, to test the immune system and check for certain diseases, such as Lyme disease."

See- Brian Fallon @ www.columbia-lyme.org   This is a published chapter in the Sadock's 2002 Comprehensive Textbook of Psychiatry.

 

Ruling out Lyme disease in Bipolar disorder in children and Adolescents:

http://www.clinicaltrials.gov/ct/gui/show/NCT00006177?order=1

Study ID Numbers  000198;  00-M-0198
ClinicalTrials.gov
skipnav Home | Search | Browse | Resources | Help | What's New | About r

Symptoms and Causes of Bipolar Disorder in Children and Adolescents

This study is currently recruiting patients.

Sponsored by

National Institute of Mental Health (NIMH)

Purpose

The purpose of this study is to learn more about and describe the moods and behaviors of children with bipolar disorder. This study will also examine what happens in the brain to produce these moods and behaviors. This is not a treatment study; children will not receive any new or experimental therapies

Children and adolescents ages 6 through 17 with bipolar disorder and normal healthy volunteers (controls) of the same age group may participate in this study. Candidates will have a telephone interview and review of medical records to determine eligibility. Additional screening will include a medical and psychiatric history of the patient and extended family members, and a physical and neurological evaluation. The medical history interviews will be videotaped and kept confidential.

Study participants will have a 3-day baseline evaluation, including the following physiologic tests and procedures:

1. Questionnaires and interviews about the subject's mood and behavior, stressful family events, and so forth, and observation and documentation of the subject's behavior twice daily by clinical staff.

2. Computer and written tests to assess intelligence, memory, learning, motor skills, reaction time, and planning skills.

3. Tests to measure heart rate, sweating, brain wave activity and eyeblinking while watching film clips that elicit various emotions and while playing computer games. Recordings include electromyogram, electrooculogram, heart rate, skin conductance, and electroencephalogram.

4. Needlestick to collect 3 tablespoons of blood to measure blood count and thyroid levels, liver and kidney function, to test the immune system and check for certain diseases, such as Lyme disease.

5. Magnetic resonance imaging (MRI) of the brain.

When the baseline evaluation is completed, the subject will return home for a 28-day period of "at-home observation." The subject and parent will complete daily questionnaires, and a NIMH staff member will observe the patient's behavior at home and at school for 2 days during this period. The observations will be videotaped and kept confidential.

At the end of the at-home observations, the subject and parent will return to the clinic for a 2-day evaluation that will include questionnaires, repeat physiologic tests described above, and a urine sample to check for drugs.

After this evaluation, control subjects will have completed their participation in the study. Follow-up evaluations will be scheduled for patients only as follows: at the end of 2 months, then every 3 months until a year has passed from the first visit, then every 6 months for 4 years. Some visits will involve only interviews and questionnaires, some will also include a physical exam, and urine test and others will also include a blood tests. A MRI brain scan will be done at 2 and 4 years.

Patients, their parents and siblings will also be asked to have blood drawn to obtain a DNA sample for genetic studies.

Condition
Bipolar Disorder
Healthy

MEDLINEplus related topics:  Bipolar Disorder
 

Study Type: Observational
Study Design: Natural History

Official Title: The Phenomenology and Neurophysiology of Affective Dysregulation in Children and Adolescents with Bipolar Disorder

Further Study Details: 

Families who are interested in participating receive an extensive telephone interview and those who are judged to be likely to meet inclusion criteria are invited to the NIMH. There, study participants have a 5-day baseline evaluation, including physiologic tests and procedures, neuropsychological testing, and questionnaires and interviews about mood and behavior. In addition, staff members obtain a medical and psychiatric history of the patient and extended family members, and a physical and neurological evaluation. Participants are asked to perform computer and written tests to assess intelligence, memory, learning, motor skills, reaction time, and planning skills. Psychophysiological measures (such as heart rate, skin conductance, and electroencephalogram) are obtained in response to emotions and while playing computer games. Participants are asked to give blood samples for blood count and thyroid levels, liver and kidney function and to check for other diseases. Structural magnetic resonance imaging (MRI) scans of the brain are obtained.

After baseline evaluation, participants return home for a 28-day period of "at-home observation." Participants and parents complete brief daily questionnaires and participants wear an activity monitor on their wrist. Participants and parents then return to the NIH for repeat evaluations and physiologic tests after 2 months, and then every 3 months until 12 months have passed from the first visit. Thereafter, visits are every 6 months for 4 years. Some visits will involve only interviews and questionnaires, some will also include a physical exam, blood tests, and urine tests. Repeated MRI brain scan will be done at 2 and 4 years. Patients, their parents and siblings will also be asked to have blood drawn to obtain a DNA sample for genetic studies.

All tests and procedures are provided free of charge, and travel expenses are paid by the NIMH.

Eligibility

Genders Eligible for Study:  Both

 

Accepts Healthy Volunteers

Criteria

BIPOLAR PATIENTS:
Boys and girls must be ages 6-17 and meet DSM-IV criteria for bipolar disorder.
The child must have a primary caregiver who can accompany him or her on trips to NIMH, provide reliable history information, and complete daily rating scales and sleep logs.
Patients must have a psychiatrist who provides clinical care for their Bipolar Disorder.
All youth accepted into the study must be able to complete self-rating forms and to cooperate with other study procedures.
Subjects must be on a stable medication regimen for at least 14 days prior to enrollment in the study. In addition, they, their parents, and treating physician must agree to keep medications stable (with the exception of minor dosage adjustments) until the end of the second NIMH evaluation, if clinically feasible and acceptable. The total duration of the medication-stable period will be approximately six weeks.
Patients must have an I.Q. greater than or equal to 70.
Patients must not have autistic disorder or severe pervasive developmental disorder.
Patients must not have psychosis that interferes with the child's capacity to understand and comply with study procedures.
Patients must not have an unstable medical illness (e.g., severe asthma).
Patients must not have a medical illness that could cause the symptoms of bipolar illness (e.g., multiple sclerosis, thyroid disease).
Patients must not be pregnant.
Patients must not have engaged in substance abuse within two months of the initial evaluation.
CONTROLS:
Healthy normal volunteers.
Control subjects will be age- and sex- matched to the patients.
They will have normal physical and neurological examinations, and an identified primary care physician.
Both control subjects and their first-degree relatives must be free of current or past psychopathology.
Controls must have an I.Q. greater than or equal to 70.
Controls must not have ongoing medical illness.
Controls must not have neurologic disorder (including seizures).
Controls must not be pregnant.
Controls must not have engaged in past or present substance abuse.
Controls must not have a history of sexual abuse.

Expected Total Enrollment:  400

Location and Contact Information

Maryland
 
National Institute of Mental Health (NIMH), 9000 Rockville Pike,  Bethesda,  Maryland,  20892,  United States; Recruiting
   Patient Recruitment and Public Liaison Office  1-800-411-1222  prpl@mail.cc.nih.gov 
   TTY  1-866-411-1010 

More Information

Detailed Web Page

Publications

Geller B, Sun K, Zimerman B, Luby J, Frazier J, Williams M. Complex and rapid-cycling in bipolar children and adolescents: a preliminary study. J Affect Disord. 1995 Aug 18;34(4):259-68.

Wozniak J, Biederman J, Kiely K, Ablon JS, Faraone SV, Mundy E, Mennin D. Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. J Am Acad Child Adolesc Psychiatry. 1995 Jul;34(7):867-76.

Faedda GL, Baldessarini RJ, Suppes T, Tondo L, Becker I, Lipschitz DS. Pediatric-onset bipolar disorder: a neglected clinical and public health problem. Harv Rev Psychiatry. 1995 Nov-Dec;3(4):171-95. Review.

 

Study ID Numbers  000198;  00-M-0198
 
Study Start Date August 9, 2000
Record last reviewed  July 30, 2002
Last Updated  July 30, 2002
NLM Identifier  NCT00006177
ClinicalTrials.gov processed this record on 2003-05-01
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act